View in EDS

A phase 1a, first-in-human, randomized study of a respiratory syncytial virus F protein vaccine with and without a toll-like receptor-4 agonist and stable emulsion adjuvant.

Saved in:
Bibliographic Details
Title: A phase 1a, first-in-human, randomized study of a respiratory syncytial virus F protein vaccine with and without a toll-like receptor-4 agonist and stable emulsion adjuvant.
Authors: Falloon, Judith1 FalloonJ@MedImmune.com, Ji, Fei1, Curtis, Craig2, Bart, Stephan3, Sheldon, Eric4, Krieger, Diane4, Dubovsky, Filip1, Lambert, Stacie5, Takas, Therese1, Villafana, Tonya1, Esser, Mark T.1
Source: Vaccine. May2016, Vol. 34 Issue 25, p2847-2854. 8p.
Database: Environment Complete
Description
ISSN:0264410X
DOI:10.1016/j.vaccine.2016.04.002